Lytix Biopharma AS (LYTIX) — Free Cash Flow Generation Index
Latest as of September 2021:
1.04x
Lytix Biopharma AS (LYTIX) has a Free Cash Flow Generation Index of 1.04x as of September 2021. Free cash flow of Nkr144.09 Million represents 1% of operating cash flow (Nkr138.23 Million). Explore Lytix Biopharma AS capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
1.04x
Free Cash Flow / Operating CF
Free Cash Flow
Nkr144.09 Million
NOK
Operating Cash Flow
Nkr138.23 Million
NOK
Capital Expenditures
Nkr35.00K
NOK
Annual Free Cash Flow Generation for Lytix Biopharma AS (None–None)
Year-by-year Free Cash Flow Generation Index for Lytix Biopharma AS. Check Lytix Biopharma AS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (NOK) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).